These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 18582908)

  • 1. Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens.
    Hipólito L; Sánchez-Catalán MJ; Zanolini I; Polache A; Granero L
    Neuropharmacology; 2008 Aug; 55(2):183-9. PubMed ID: 18582908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats.
    Matsuzaki S; Ikeda H; Akiyama G; Sato M; Moribe S; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuropharmacology; 2004 Jun; 46(8):1089-96. PubMed ID: 15111015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
    Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
    Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation.
    Churchill L; Kalivas PW
    Synapse; 1992 May; 11(1):47-57. PubMed ID: 1318584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumbal core: essential link in feed-forward spiraling striato-nigro-striatal in series connected loop.
    Ikeda H; Koshikawa N; Cools AR
    Neuroscience; 2013 Nov; 252():60-7. PubMed ID: 23933312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple opioid receptors mediate feeding elicited by mu and delta opioid receptor subtype agonists in the nucleus accumbens shell in rats.
    Ragnauth A; Moroz M; Bodnar RJ
    Brain Res; 2000 Sep; 876(1-2):76-87. PubMed ID: 10973595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity.
    Unterwald EM; Cox BM; Kreek MJ; Cote TE; Izenwasser S
    Synapse; 1993 Sep; 15(1):33-8. PubMed ID: 8310423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine alters mu but not delta or kappa opioid receptor-stimulated in situ [35S]GTPgammaS binding in rat brain.
    Schroeder JA; Niculescu M; Unterwald EM
    Synapse; 2003 Jan; 47(1):26-32. PubMed ID: 12422370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of dopamine receptor antagonism upon feeding elicited by mu and delta opioid agonists in the shell region of the nucleus accumbens.
    Ragnauth A; Znamensky V; Moroz M; Bodnar RJ
    Brain Res; 2000 Sep; 877(1):65-72. PubMed ID: 10980244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamine mapping within nucleus accumbens: differences in basal and amphetamine-stimulated efflux of norepinephrine and dopamine in shell and core.
    McKittrick CR; Abercrombie ED
    J Neurochem; 2007 Mar; 100(5):1247-56. PubMed ID: 17241132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrochemical evidence of increased dopamine transmission in prefrontal cortex and nucleus accumbens elicited by ventral tegmental mu-opioid receptor activation in freely behaving rats.
    Noel MB; Gratton A
    Synapse; 1995 Oct; 21(2):110-22. PubMed ID: 8584972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal opioid-opioid interactions between the ventral tegmental area and nucleus accumbens regions in mediating mu agonist-induced feeding in rats.
    Bodnar RJ; Lamonte N; Israel Y; Kandov Y; Ackerman TF; Khaimova E
    Peptides; 2005 Apr; 26(4):621-9. PubMed ID: 15752577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus.
    Klitenick MA; Kalivas PW
    J Pharmacol Exp Ther; 1994 Apr; 269(1):437-48. PubMed ID: 8169850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
    Latimer LG; Duffy P; Kalivas PW
    J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
    Gyires K; Rónai AZ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.
    Yoshida Y; Koide S; Hirose N; Takada K; Tomiyama K; Koshikawa N; Cools AR
    Neuroscience; 1999; 92(4):1357-65. PubMed ID: 10426490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
    Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms.
    Murakawa K; Hirose N; Takada K; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Eur J Pharmacol; 2004 Apr; 491(1):31-6. PubMed ID: 15102530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.